Biotech

All Articles

' Scientific intuitiveness' led FDA specialists to back Zevra's rare condition med

.Zevra Therapies' unusual illness medication seems to be to be on the course to confirmation this fa...

Pfizer takes $230M attacked after axing failed DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene therapy failure has actually gone a $230 thou...

AC Immune views 'spots' prospective in Alzheimer's medicine data

.After much more than twenty years of service neurodegenerative ailments, Swiss biotech hvac Immune ...

GSK drops ph. 2 HPV injection over shortage of best-in-class possible

.GSK has actually broken up a period 2 human papillomavirus (HPV) vaccination coming from its own pi...

OS Therapies refiles $6M IPO to cash HER2 medication, preclinical ADCs

.Operating system Therapies will certainly note on the NYSE American inventory swap today through a ...

ALX's waning CD47 feedback rate delivers sell spiraling down

.ALX Oncology's stage 2 stomach cancer action price has deteriorated. After seeing its CD47 blocker ...

Ionis axes eye health condition from targets of Roche-partnered prospect after records disappoint

.An Additional of Ionis Pharmaceuticals' vital midphase readouts has disappointed assumptions, causi...

Biogen's CEO claimed no high-risk handle 2023. He's ready to become vibrant

.While Biogen's pharma peers are actually seeking for late-stage possessions with little bit of thre...

Instil refills pipe in $2B biobucks manage ImmunOnco

.Instil Biography has actually been a biotech in search of a pipe after it scrapped its lead resourc...

Biogen walks away from Denali Alzheimer's collab

.Biogen has returned civil liberties to an early Alzheimer's illness course to Denali Therapeutics, ...